Establishment

Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries

Retrieved on: 
Thursday, September 2, 2021
Oncology, Medical Devices, Health, Consumer, Surgery, Women, Private Securities Litigation Reform Act, Form 10-K, Securities Act of 1933, IDE, U.S. Securities and Exchange Commission, Partnership, RFID, Breast reconstruction, Annual report, Security (finance), Surgeon, Time, Drug Quality and Security Act, MRI, Diversified Specialty Institute Holdings, Inc., Environment, Securities Exchange Act of 1934, Establishment, Risk, FDA, Woman, Adoption, Clinical trial, 21 CFR 820, MDSAP, ESTA, Goal, Motiva, NASDAQ, Medical device, Medical imaging

Other participants on the panel included reconstructive surgeons with experience using Motiva Flora and members of the medical and scientific advisory boards of Establishment Labs.

Key Points: 
  • Other participants on the panel included reconstructive surgeons with experience using Motiva Flora and members of the medical and scientific advisory boards of Establishment Labs.
  • In Europe, breast reconstruction represents 20% or more of the breast implant market, added Juan Jos Chacn-Quirs, Founder and Chief Executive Officer of Establishment Labs.
  • The Motiva Flora tissue expander offers several notable innovations, including Establishment Labs patented SmoothSilk surface technology as well as an RFID-enabled, non-magnetic integrated port, that offer potential improvements in imaging, treatment, and overall clinical outcomes and patient satisfaction.
  • The Motiva Flora tissue expander is currently not approved for commercial distribution in the United States.

Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021

Retrieved on: 
Friday, August 20, 2021
Surgery, Medical Devices, Women, Consumer, Health, Private Securities Litigation Reform Act, Securities Exchange Act of 1934, Annual report, Program, MDSAP, Securities Act of 1933, ESTA, Adoption, U.S. Securities and Exchange Commission, RFID, Establishment, Time, Motiva, Risk, Clinical trial, NASDAQ, Goal, Environment, IDE, 21 CFR 820, Q&A, FDA, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Security (finance), Form 10-K, Pharmaceutical industry, Risk management

The symposium will feature members of the medical and scientific advisory boards of Establishment Labs and reconstructive surgeons who participated in the earlier limited launch of Motiva Flora.

Key Points: 
  • The symposium will feature members of the medical and scientific advisory boards of Establishment Labs and reconstructive surgeons who participated in the earlier limited launch of Motiva Flora.
  • In addition, members of Establishment Labs management team will outline the potential market opportunity and commercialization plans for Motiva Flora.
  • The symposium is part of the official program of the 2021 London Breast Meeting and will be held on Thursday, September 2 at 3pm BST.
  • The Motiva Flora tissue expander is currently not approved for commercial distribution in the United States.

Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO

Retrieved on: 
Friday, August 13, 2021
Tablet, Income, Nano, EBITDA, Growth, NASDAQ, Table, U.S. Securities and Exchange Commission, Excipient, DEA, Goal, Company, Liposome, Loss, Securities Act of 1933, COVID-19, GLOBE, LLC, Phrase, Drug discovery, GAAP, Acquisition, CDMO, Establishment, Drug Quality and Security Act, Security (finance), Leadership, L.L.C, William Blair & Company, Securities Exchange Act of 1934, Depreciation, Solution, Bank, Risk management, Fine chemical, Financial services, Vaccine, Bookkeeping

EXTON, Pa., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced its acquisition of IRISYS, a San Diego-based CDMO that possesses capabilities that complement and expand those of Recro. Recro acquired IRISYS for approximately $50 million in a combination of cash, shares of Recro common stock and a seller promissory note. With its acquisition of IRISYS, Recro has transformed itself into a full service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for wide range of dosage forms.

Key Points: 
  • Recro acquired IRISYS for approximately $50 million in a combination of cash, shares of Recro common stock and a seller promissory note.
  • Adding the personnel, facilities, capabilities and global customer base of IRISYS advances each of these goals and positions Recro for sustainable, profitable growth moving forward.
  • We welcome the members of the IRISYS team to the Recro family and are eager to begin implementing the integration of the companies.
  • Recro (NASDAQ: REPH ) is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing.

Great Gulf - First Canadian Developer to Break Ground in Washington DC's Union Market District

Retrieved on: 
Wednesday, November 14, 2018
Software, Computing, World Wide Web, Social media, Social networking services, Photo sharing, Universal Windows Platform apps, Instagram, Twitter, Facebook, Marketplace, Establishment

TORONTO, Nov. 14,2018 /PRNewswire/ - Great Gulf, an international award-winning developer, brings its Canadian know-how to the nation's US capital as the first Canadian company to break ground in DC's vibrant Union Market District.

Key Points: 
  • TORONTO, Nov. 14,2018 /PRNewswire/ - Great Gulf, an international award-winning developer, brings its Canadian know-how to the nation's US capital as the first Canadian company to break ground in DC's vibrant Union Market District.
  • Attended by local government officials, Canadian Embassy representatives and special guests, the event marked a significant milestone in Great Gulf's expansion into the U.S. market.
  • "Union Market District is about establishing and honoring authentic relationships with our neighbors.
  • For more information about the Union Market District, please visit www.unionmarketdc.com or follow @UnionMarketDC on Instagram, Facebook and Twitter.